Medicxi IV LP - Dec 27, 2024 SCHEDULE 13G Report for RAPT Therapeutics, Inc. Common Stock, $0.0001 par value (RAPT)

Filing Manager
Medicxi IV LP
Reporting Manager
Medicxi IV GP Limited
Security
RAPT Therapeutics, Inc. Common Stock, $0.0001 par value
Symbol
RAPT
Shares outstanding
132M shares
Disclosed Ownership
22.4M shares
Ownership
16.9%
Form type
SCHEDULE 13G
Date filed
1/6/2025, 09:22 AM
Date of event
Dec 27, 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Medicxi IV LP 16.6% 22M 22M 0 /s/ Giles Johnstone-Scott Giles Johnstone-Scott, Director of Manager
Medicxi Co-Invest IV LP 0.3% 374K 374K 0 /s/ Giles Johnstone-Scott Giles Johnstone-Scott, Director of Manager
Medicxi IV GP Limited 16.9% 22.4M 22.4M 0 /s/ Nigel Crocker Nigel Crocker, Alternate Director
Medicxi Ventures Management (Jersey) Limited 16.9% 22.4M 22.4M 0 /s/ Giles Johnstone-Scott Giles Johnstone-Scott, Director